| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |